VALN · Valneva SE
Market Cap
$609.71M
Shares
94.82M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-16 00:00 UTC | Jefferies Global Healthcare Conference | Conference |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-13 | Earnings conference call (announced in 6-K) | Earnings call |
| 2026-06-25 | Annual General Meeting 2026 | Event |
| 2026-06-03 | Northern European Conference on Travel Medicine NECTM10 | Conference |
| 2026-05-13 | Q1 2026 Financial Results | Earnings call |
| 2026-05-13 | Earnings conference call (announced in 6-K) | Earnings call |
| 2026-03-30 | World Vaccine Congress | Event |
| 2026-03-18 | FY 2025 Financial Results | Earnings call |
| 2026-03-18 | Earnings conference call (announced in 6-K) | Earnings call |
| 2026-03-10 | 2026 Jefferies Biotech on the Beach Summit | Event |
| 2026-03-04 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-19 | FY 2025 Revenue and Cash Press Release | Event |
| 2025-12-18 | Goldman Catalyst Clinic (virtual) | Event |
| 2025-11-26 | Euronext Tech Leaders | Event |
Source: https://valneva.com/investors/
Key facts
CIK
1836564
CUSIP
92025Y103
13F (30d)
15 filings
15 filers
Visit website
Investor relations